Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice
Erik B. Faber, Nan Wang, Kristen John, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1928-1940
Closed Access | Times Cited: 16

Showing 16 citing articles:

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
Erik B. Faber, Luxin Sun, Jian Tang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Reversible male contraception by targeted inhibition of serine/threonine kinase 33
Angela F. Ku, Kiran Sharma, Hai Minh Ta, et al.
Science (2024) Vol. 384, Iss. 6698, pp. 885-890
Closed Access | Times Cited: 10
Iodopentafluorosulfanylation of [1.1.1]propellane and further functionalizations
Xin Zhao, Jia‐Yi Shou, Feng‐Ling Qing
Science China Chemistry (2023) Vol. 66, Iss. 10, pp. 2871-2877
Closed Access | Times Cited: 17
A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 3
Recent advances in the chemistry and the application of SF5-compounds
Mariam Abd El Sater, Lucas Popek, Nicolas Blanchard, et al.
Synthesis (2024)
Closed Access | Times Cited: 3
Sperm Toolbox—A selection of small molecules to study human spermatozoa
Franz S Gruber, Anthony Richardson, Zoe C Johnston, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297666-e0297666
Open Access | Times Cited: 2
Design, synthesis, and biological evaluation of N-(pyridin-3-yl)pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy
Wen-Bin Zeng, Tangyang Ji, Yanting Zhang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107019-107019
Closed Access | Times Cited: 7
Targeting Cyclin-Dependent Kinases: From Pocket Specificity to Drug Selectivity
Yaoguang Huang, Wenwu Liu, Changhao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116547-116547
Closed Access | Times Cited: 1
Nanomaterials Solutions for Contraception: Concerns, Advances, and Prospects
Zhenning Su, Tian Diao, Helen M. McGuire, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20753-20775
Closed Access | Times Cited: 3
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng, Xiaodong Ren, Pengyao Jin, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1125-1148
Closed Access
Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023)
Yumei Jin, Hao Lu, Ge Hu, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e195-e220
Open Access
Novel Genes of the Male Reproductive System: Potential Roles in Male Reproduction and as Non‐hormonal Male Contraceptive Targets
Thomas X. Garcia, Martin M. Matzuk
Molecular Reproduction and Development (2024) Vol. 91, Iss. 10
Closed Access
Sperm Toolbox – A selection of small molecules to study human spermatozoa
Franz S Gruber, Anthony Richardson, Zoe C Johnston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Spy1-activated Cyclin Dependent Kinase 2 Shows Reduced Affinity for Current Synthetic Small Molecule Inhibitors of the CDK2-Cyclin Complex
Daniel Meister, John J. Hayward, Bre‐Anne Fifield, et al.
(2023)
Open Access | Times Cited: 1
Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo
Ratnakar Reddy Kuchukulla, Injeoung Hwang, Suhn Hyung Kim, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116014-116014
Open Access | Times Cited: 1
RECENT ADVANCES IN THE DISCOVERY OF CYCLIN-DEPENDENT KINASE 2 (CDK2) SELECTIVE INHIBITORS
Kevin D. Freeman‐Cook, Robert L. Hoffman
Medicinal chemistry reviews (2023), pp. 283-311
Closed Access
Page 1

Scroll to top